소화기과 외래 수술 센터 시장 : 서비스별, 적응증별, 의료 레벨별, 환자층별, 용도별, 최종 사용자별, 소유 형태별 - 세계 예측(2026-2032년)

The Gastroenterology Ambulatory Surgery Center Market was valued at USD 7.60 billion in 2025 and is projected to grow to USD 8.21 billion in 2026, with a CAGR of 8.59%, reaching USD 13.55 billion by 2032.

An incisive introduction to ambulatory gastroenterology centers highlighting clinical scope operational diversity and patient-centric service evolution

The ambulatory surgery center (ASC) model for gastroenterology is reshaping how diagnostic and therapeutic procedures are delivered, driven by clinical innovation, patient preference for convenience, and efficiencies in care pathways. In recent years, advances in endoscopic technology, minimally invasive surgical techniques, and perioperative management have expanded the range of procedures safely performed in outpatient settings. As a result, facilities that concentrate on gastroenterology are evolving into high-capacity hubs that deliver capsule endoscopy, colonoscopy, and a wide spectrum of upper and lower gastrointestinal procedures while maintaining streamlined observation and same-day surgery services.

Operational structures vary across clinics and physicians' offices, hospital-affiliated units, and independent ASCs, while ownership models range from corporation-owned platforms to freestanding and hospital-aligned centers. Patient demographics span pediatric care through adult and geriatric populations, requiring tailored clinical protocols, recovery pathways, and perioperative support. Moreover, the application landscape incorporates diagnostic tests, endoscopy procedures, and therapeutic interventions such as endoscopic mucosal resection and submucosal dissection, which are increasingly performed outside traditional inpatient settings. This convergence of capabilities and patient-centered design positions gastroenterology ASCs as a pivotal part of modern care delivery, delivering high-value, lower-cost alternatives that emphasize throughput, safety, and patient experience.

How converging clinical innovations reimbursement shifts and workforce dynamics are accelerating outpatient gastroenterology care transformation

The landscape of gastroenterology ambulatory surgery centers is undergoing transformative shifts driven by technological innovation, care delivery redesign, and workforce evolution. High-resolution imaging, capsule endoscopy, and next-generation endoscopes are improving diagnostic yield while advanced therapeutic options such as endoscopic mucosal resection, submucosal dissection, and refined polypectomy techniques are expanding the therapeutic scope possible in same-day settings. Concurrently, minimally invasive surgical approaches including laparoscopic gastrointestinal surgeries and targeted procedures like sphincterotomy and hernia repair are migrating toward outpatient platforms as perioperative protocols and anesthesia techniques reduce recovery times.

Payment reforms and value-based contracting are incentivizing site-of-care optimization, accelerating the transfer of lower-acuity, high-volume procedures from inpatient hospitals to independent ASCs and clinic-based settings. Telehealth and remote preoperative assessment tools are enhancing throughput and reducing no-show rates, while integrated electronic health records and procedural analytics enable continuous quality improvement and real-time case management. Workforce dynamics-particularly the need for advanced endoscopy-trained clinicians, perioperative nurses, and specialized technicians-are prompting investments in training and retention programs. Lastly, patient expectations for convenience, transparency, and rapid access have intensified competition, compelling providers to differentiate through care coordination, same-day surgery pathways, and enhanced recovery protocols that collectively shift the balance of care toward ambulatory environments.

Assessing the cumulative operational and procurement consequences of 2025 tariff dynamics on ambulatory gastroenterology services and capital planning

Policy shifts related to tariffs and trade in 2025 have introduced a new set of considerations for supply chains, capital planning, and procurement strategies for gastroenterology ASCs. Many diagnostic and therapeutic devices, disposables, and endoscopy accessories rely on global manufacturing networks; increases in import duties or trade frictions can raise acquisition costs and introduce variability into lead times. For providers focused on capital-intensive upgrades such as purchasing advanced endoscopes or minimally invasive surgical systems, tariff-induced cost pressures require re-evaluation of replacement cycles, leasing versus purchasing decisions, and total cost of ownership assessments.

The cumulative effect extends beyond device cost to inventory management and contracting behavior. Facilities are responding by diversifying supplier portfolios, negotiating fixed-price multi-year contracts, and exploring regional manufacturing partnerships to mitigate exposure. Independent ASCs, with typically narrower purchasing scale compared to large hospital systems, may seek group purchasing arrangements or strategic alliances to restore bargaining parity. At the same time, tariff-related price increases can accelerate consolidation as organizations pursue operational scale to absorb cost shocks. Reimbursement frameworks that do not keep pace with rising input costs will place margin pressure on lower-reimbursed procedures performed in ambulatory settings, prompting leadership to optimize case mix, enhance coding and documentation practices, and pursue higher-value therapeutic interventions that align with payer priorities. Ultimately, a strategic and differentiated supply-chain response combined with proactive financial modeling will be essential for maintaining service continuity and preserving investment in innovation under tariff uncertainty.

Integrated segmentation analysis revealing how service types indications levels of care and ownership models shape strategic priorities in gastroenterology ASCs

A nuanced segmentation view illuminates where clinical opportunity and operational focus intersect across the gastroenterology ASC landscape. When analyzed by services, diagnostic capabilities extend from capsule endoscopy and colonoscopy to esophageal manometry, flexible sigmoidoscopy, and upper endoscopy, feeding a high-throughput workflow that supports early detection and streamlined referrals. Surgical services encompass bariatric procedures, cholecystectomy, colorectal surgery, inguinal hernia repair, and a growing array of laparoscopic gastrointestinal surgeries, while therapeutic offerings such as endoscopic mucosal resection, endoscopic submucosal dissection, hemorrhoid ligation, polypectomy, and sclerotherapy create pathways for definitive outpatient care that reduce inpatient demand.

Viewing the environment through the lens of indication highlights priorities in colorectal cancer screening, gastrointestinal infections, inflammatory bowel diseases, and liver cirrhosis, each requiring distinct diagnostic algorithms, peri-procedural risk stratification, and post-procedure follow-up. The level of care axis-observation versus same-day surgery-shapes staffing patterns, recovery room design, and scheduling practices to maximize throughput while preserving patient safety. Patient demographics also drive differential service models: pediatric cases demand age-appropriate sedation and family-centered workflows, adult pathways emphasize screening and chronic disease management, and geriatric populations require comorbidity-aware preoperative evaluation and enhanced recovery protocols.

Application-driven segmentation further clarifies resource allocation between diagnostic tests, endoscopy suites, and therapeutic interventions, influencing capital expenditure priorities and clinical competency development. End-user distinctions across clinics and physicians' offices, hospitals, and independent ASCs determine referral flows, case complexity, and negotiation leverage with payers and suppliers. Finally, ownership models-corporation-owned platforms, freestanding centers, and hospital-affiliated units-affect strategic orientation toward growth, scale, and integration; each structure brings trade-offs in capital access, operational autonomy, and the ability to standardize clinical protocols. Together, these segmentation lenses provide a comprehensive framework for aligning clinical services with financial strategy and patient needs.

Comparative regional dynamics and strategic considerations shaping adoption reimbursement and capacity building across Americas EMEA and Asia-Pacific

Regional dynamics substantially influence operational models, adoption curves for advanced procedures, and regulatory-compliance requirements across the globe. In the Americas, mature reimbursement infrastructures and a strong trend toward outpatient migration have driven rapid adoption of endoscopy-focused ASCs and independent surgical centers, with particular emphasis on colorectal cancer screening programs and efficiency-driven same-day surgery workflows. North American centers often leverage consolidated purchasing and established accreditation frameworks to standardize quality and drive down per-procedure costs, while market participants experiment with bundled-payment arrangements and partnerships with payer networks.

Across Europe, the Middle East, and Africa, heterogeneous reimbursement regimes and regulatory conditions create a mosaic of adoption rates. Western European systems frequently emphasize integrated care pathways and public-private collaboration, enabling hospital-affiliated ASCs to scale diagnostic and therapeutic endoscopy programs. In contrast, emerging markets within the region present opportunities for capacity-building, technology transfer, and targeted investments in high-impact services such as management of inflammatory bowel disease and gastrointestinal infection control. Regulatory variability also influences device registration timelines and cross-border procurement strategies.

The Asia-Pacific region demonstrates rapid uptake of minimally invasive and endoscopic therapeutic techniques, driven by rising demand for elective procedures, growing geriatric populations, and expanding private healthcare infrastructure. Local manufacturing footprints are strengthening in several countries, which can mitigate exposure to international trade disruptions and support competitive pricing. However, disparities in clinician training, reimbursement reform, and urban-rural access persist, requiring tailored strategies that combine workforce development, telehealth-enabled triage, and phased capital deployment to scale ambulatory gastroenterology capabilities effectively.

Competitive dynamics and partnership strategies among device makers ASC operators and integrated health systems driving innovation and operational scale

The competitive landscape for gastroenterology ambulatory services is defined by device manufacturers, technology innovators, ASC operators, and integrated health systems that pursue scale through clinical differentiation and partnerships. Device and consumable suppliers are prioritizing durability, image clarity, and disposable options that reduce cross-contamination risk while enabling cost-effective throughput. Vendors that couple hardware with analytics, remote monitoring, and service-level agreements provide ASC operators with tools to optimize uptime and procedural efficiency.

ASC operators and health systems are responding by forging alliances with technology partners, pursuing targeted acquisitions to expand geographic reach, and investing in center-of-excellence models that concentrate complex endoscopic procedures. Strategic purchasers are also focusing on vertical integration opportunities, such as combined ambulatory networks that include preoperative assessment platforms, centralized scheduling, and standardized clinical protocols to drive consistency and economies of scale. Emerging service models emphasize joint ventures between physician groups and corporate entities to balance clinical control with capital access. Across the ecosystem, the most successful organizations are those that balance clinical innovation with disciplined operational execution, leveraging supply-chain resilience, clinician engagement, and payer relationships to sustain growth and quality.

Actionable strategic directives for executive leaders to strengthen clinical capabilities diversify supply chains and capture value in ambulatory gastroenterology

Leaders in ambulatory gastroenterology should adopt a proactive, multi-dimensional strategy to capture clinical and economic value while mitigating downside risks. First, prioritize investment in diagnostic and therapeutic endoscopy capabilities that deliver high clinical yield and procedural efficiency, supported by structured training programs to scale clinician competency. Second, diversify procurement through multi-supplier contracts, regional manufacturing partnerships, and participation in cooperative purchasing arrangements to reduce exposure to supply-side shocks and tariff-related cost volatility. Third, refine service mix and throughput by expanding same-day surgery protocols, enhancing preoperative telehealth assessments, and optimizing observation pathways to reduce length of stay without compromising safety.

Additionally, pursue partnerships with payers and health systems to develop value-based arrangements for high-volume interventions such as colorectal cancer screening and chronic disease management programs, thereby aligning incentives for quality and cost control. Invest in digital infrastructure that integrates scheduling, perioperative documentation, and analytics to monitor outcomes and identify efficiency opportunities. For ownership groups, evaluate consolidation and joint-venture models to achieve the scale necessary for competitive procurement and capital access. Finally, emphasize patient experience and transparency to strengthen referral relationships and capture market share; clear communication about procedure expectations, recovery timelines, and cost can differentiate centers in increasingly consumer-driven care pathways.

A transparent mixed-methods research methodology combining primary interviews secondary evidence and scenario analysis to produce actionable ASC insights

The research underpinning this executive summary synthesizes primary and secondary investigative approaches to ensure rigor and relevance. Primary inputs included structured interviews with clinicians, ASC administrators, supply-chain professionals, and payers, providing qualitative insights into procedural workflows, procurement priorities, and reimbursement interactions. Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, device performance documentation, and public filings to corroborate clinical trends and technological capabilities.

Analytical techniques employed triangulate qualitative observations with operational metrics such as throughput, case-mix complexity, and resource utilization to generate a coherent picture of current practice patterns. Segmentation analyses were conducted across services, indications, levels of care, patient demographics, applications, end-users, and ownership structures to surface differentiated strategies appropriate to each segment. Regional comparisons drew on policy analyses and adoption indicators to map readiness across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Where uncertainty exists-particularly around trade policy and reimbursement changes-scenario-based analysis was used to outline plausible operational responses and financial sensitivities. The methodology emphasizes transparency, reproducibility, and actionable insights tailored for strategic decision-making.

Concluding synthesis on why strategic alignment clinical investment and supply chain resilience determine long-term success for gastroenterology ASCs

Ambulatory gastroenterology centers sit at the intersection of clinical innovation, operational engineering, and changing consumer expectations, presenting both significant opportunities and clear execution challenges. Advances in diagnostic and therapeutic endoscopy, coupled with improvements in perioperative care, enable a broader set of procedures to transition to same-day and observation-based models, improving access and reducing total cost of care. However, external pressures including tariff volatility, supply-chain exposure, and uneven regional reimbursement frameworks require strategic responses that balance investment in clinical capability with disciplined operational and procurement practices.

Organizations that succeed will be those that align service portfolios with population needs, invest in clinician training and digital workflows, diversify supply chains to maintain resilience, and pursue partnership structures that provide capital and scale without sacrificing clinical autonomy. By focusing on value-measured through outcomes, patient experience, and total cost-providers can position ambulatory gastroenterology centers as a preferred site of care for a growing range of diagnostic and therapeutic interventions. Thoughtful execution, rigorous quality management, and adaptive strategy will determine which centers capitalize on the shift toward outpatient gastrointestinal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroenterology Ambulatory Surgery Center Market, by Services

• 8.1. Diagnostic Services
  • 8.1.1. Capsule Endoscopy
  • 8.1.2. Colonoscopy
  • 8.1.3. Esophageal Manometry
  • 8.1.4. Flexible Sigmoidoscopy
  • 8.1.5. Upper Endoscopy
• 8.2. Surgical Services
  • 8.2.1. Bariatric Surgery
  • 8.2.2. Cholecystectomy
  • 8.2.3. Colorectal Surgery
  • 8.2.4. Inguinal Hernia Repair
  • 8.2.5. Laparoscopic Gastrointestinal Surgeries
  • 8.2.6. Sphincterotomy
• 8.3. Therapeutic Services
  • 8.3.1. Endoscopic Mucosal Resection
  • 8.3.2. Endoscopic Submucosal Dissection
  • 8.3.3. Hemorrhoid Ligation
  • 8.3.4. Polypectomy
  • 8.3.5. Sclerotherapy

9. Gastroenterology Ambulatory Surgery Center Market, by Indication

• 9.1. Colorectal Cancer Screening
• 9.2. Gastrointestinal Infections
• 9.3. Inflammatory Bowel Diseases
• 9.4. Liver Cirrhosis

10. Gastroenterology Ambulatory Surgery Center Market, by Level of Care

• 10.1. Observation
• 10.2. Same-Day Surgery

11. Gastroenterology Ambulatory Surgery Center Market, by Patient Demographic

• 11.1. Adults
• 11.2. Geriatric
• 11.3. Pediatric

12. Gastroenterology Ambulatory Surgery Center Market, by Application

• 12.1. Diagnostic Tests
• 12.2. Endoscopy
• 12.3. Therapeutic Interventions

13. Gastroenterology Ambulatory Surgery Center Market, by End-User

• 13.1. Clinics & Physicians' Offices
• 13.2. Hospitals
• 13.3. Independent ASCs

14. Gastroenterology Ambulatory Surgery Center Market, by Ownership

• 14.1. Corporation-Owned
• 14.2. Freestanding
• 14.3. Hospital-Affiliated

15. Gastroenterology Ambulatory Surgery Center Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Gastroenterology Ambulatory Surgery Center Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Gastroenterology Ambulatory Surgery Center Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. United States Gastroenterology Ambulatory Surgery Center Market

19. China Gastroenterology Ambulatory Surgery Center Market

20. Competitive Landscape

• 20.1. Market Concentration Analysis, 2025
  • 20.1.1. Concentration Ratio (CR)
  • 20.1.2. Herfindahl Hirschman Index (HHI)
• 20.2. Recent Developments & Impact Analysis, 2025
• 20.3. Product Portfolio Analysis, 2025
• 20.4. Benchmarking Analysis, 2025
• 20.5. Alabama Digestive Health Endoscopy Center (AL)
• 20.6. Alfa Surgery Center, LLC
• 20.7. Athens Gastroenterology Center
• 20.8. Baptist Health South Florida, Inc.
• 20.9. Covenant Physician Partners
• 20.10. Envision Healthcare Corporation
• 20.11. Gastro Health LLC
• 20.12. Gastroenterology Associates Endoscopy Center
• 20.13. GE HealthCare Technologies Inc.
• 20.14. Gulf Coast Endoscopy Center
• 20.15. HCA Healthcare, Inc.
• 20.16. Inova McLean Ambulatory Surgery Center
• 20.17. Jupiter Outpatient Surgery Center, LLC
• 20.18. Liberty Endoscopy Center
• 20.19. OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
• 20.20. Ohio Gastroenterology Group Inc.
• 20.21. Ontario Advanced Surgery Center
• 20.22. Regent Surgical
• 20.23. SCA Health
• 20.24. Shelby Ambulatory Surgery
• 20.25. SOUTH BROWARD ENDOSCOPY, LLC
• 20.26. Tenet Healthcare Corporation
• 20.27. The Outpatient Center of Boynton Beach
• 20.28. United Digestive
• 20.29. Universal Health Services, Inc.